CN106620862A - Preparation method of collagen-hydroxyapatite scaffold containing nano silicon nitride - Google Patents

Preparation method of collagen-hydroxyapatite scaffold containing nano silicon nitride Download PDF

Info

Publication number
CN106620862A
CN106620862A CN201610952850.0A CN201610952850A CN106620862A CN 106620862 A CN106620862 A CN 106620862A CN 201610952850 A CN201610952850 A CN 201610952850A CN 106620862 A CN106620862 A CN 106620862A
Authority
CN
China
Prior art keywords
silicon nitride
nano
collagen
hydroxyapatite
nano silicon
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201610952850.0A
Other languages
Chinese (zh)
Inventor
王晓伟
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Qingdao Fengze Zte Technology Services Ltd
Original Assignee
Qingdao Fengze Zte Technology Services Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Qingdao Fengze Zte Technology Services Ltd filed Critical Qingdao Fengze Zte Technology Services Ltd
Priority to CN201610952850.0A priority Critical patent/CN106620862A/en
Publication of CN106620862A publication Critical patent/CN106620862A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/40Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • A61L27/44Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
    • A61L27/446Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix with other specific inorganic fillers other than those covered by A61L27/443 or A61L27/46
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/40Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • A61L27/44Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
    • A61L27/46Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix with phosphorus-containing inorganic fillers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54Biologically active materials, e.g. therapeutic substances
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/56Porous materials, e.g. foams or sponges
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/10Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404Biocides, antimicrobial agents, antiseptic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/62Encapsulated active agents, e.g. emulsified droplets
    • A61L2300/622Microcapsules

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Dermatology (AREA)
  • Veterinary Medicine (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Materials Engineering (AREA)
  • Composite Materials (AREA)
  • Dispersion Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention relates to a preparation method of a collagen-hydroxyapatite scaffold containing nano silicon nitride. The preparation method includes the steps of: performing a liquid-phase reduction reaction to prepare the nano silicon nitride, uniformly mixing the nano silicon nitride with a collagen-hydroxyapatite solution, and performing one-step freeze-drying and crosslinking to produce the scaffold, wherein concentration range of the nano silicon nitride is 10-50 [mu]g/ml and particle size of the nano silicon nitride is 10-30 nm. The raw materials of the scaffold are simple. The method is free of complex technology and high-end equipment, is low in cost and is easy to promote. A reasonable nano silicon nitride slow release system is provided for a wound surface, so that long-acting effective slow releasing of a medicine is provided for the wound surface, thereby maintaining the medicine concentration of the wound surface to be balanced and effective without excess.

Description

A kind of preparation method of the collagen-hydroxyapatite support containing nano-silicon nitride
Technical field
The invention belongs to technical field of biological materials, and in particular to a kind of collagen-hydroxyapatite containing nano-silicon nitride The preparation method of support.
Background technology
Hydroxyapatite and collagen are topmost inorganic and organic principles in nature bone, and all have good life Thing characteristic, but there is different defects again when being used alone, it is difficult to meet requirement of the organizational project to biomaterial performance, with Collagen preferably make use of the caking property of collagen and overcome hydroapatite particles with hydroxyapatite compound Mobility.
Nano-silicon nitride has excellent conductivity of heat, electric conductivity, surface-active and catalytic performance, in optics, catalysis, micro- electricity The fields such as son, bio-sensing, antibacterial have huge using value.The nano silicon nitride powders performance of different-shape is different, such as grain Footpath is less, narrow particle size distribution ball shaped nano silicon nitride powder has good anti-microbial property and electric conductivity.
Due to the high bioactivity of nano-silicon nitride, when applying it in organizational project, the surface of a wound or target are discharged into Organ, it preferentially can be captured by the GAP-associated protein GAP in wound exudate or tissue, chlorion and group, cause nano silicon nitride silicon grain In some position high concentration abnormal aggregations, although can effectively participate in antibacterial, but these superfluous nano-silicon nitrides will be thin in epidermis Born of the same parents, macrophage, the interior aggregation of fibroblast, cause the apoptosis of cell, ultimately result in disunion or the delayed union of the surface of a wound. Generally speaking, immoderate use or uncontrolled release nano-silicon nitride will certainly run counter to desire, and not have to wound repair Benefit.Therefore, safely and effectively using nano-silicon nitride rational slow-releasing system is needed, for the surface of a wound permanently effective medicine is provided Thing is sustained, and keeps the drug concentration of the surface of a wound balanced effective and not superfluous.
The content of the invention
The technical problem to be solved in the present invention is to provide a kind of system of the collagen-hydroxyapatite support containing nano-silicon nitride Preparation Method, is to prepare nano-silicon nitride by Liquid reduction reaction process, is then well mixed with collagen-hydroxyapatite solution latter Footwork is freezed and is crosslinked preparation becomes Metal pylon, prepares the novel nano silicon nitride biomaterial with antibacterial, safety.
The present invention is achieved by the following technical solutions:
(1) adopting silicon tetrachloride and sodium azide and adding dipotassium hydrogen phosphate carries out Liquid reduction reaction process preparation for dispersant Nano silicon nitride Ludox;Reaction temperature is 30 DEG C -45 DEG C;
(2) heating using microwave in confined conditions of nano silicon nitride Ludox is reacted, it is first anti-under 250~350W microwave powers 2~2.5min is answered, then 2.5~3min is reacted under 100~150W microwave powers, nano-silicon nitride solution is obtained;
(3) NTx albumen ox heel string originated and hydroxyapatite are according to 9:1 mass ratio is dissolved into 0.5mol/L Acetic acid solution in, added as aimed concn with 10ppm and mix 4h after a certain amount of solution to nano-silicon nitride, be subsequently adding total matter The glutaraldehyde of the 0.5% of amount is simultaneously mixed, and obtains the solution of collagen-hydroxyapatite containing nano-silicon nitride that mass fraction is 0.5%, Nano-silicon nitride, collagen-hydroxyapatite solution are injected into the mould of 4cm × 4cm, is freezed 2 hours at -20 DEG C, then frozen It is dry to obtain within 24 hours collagen-hydroxyapatite support of the porous containing nano-silicon nitride that thickness is 2mm.The concentration of nano-silicon nitride Scope is 10ug/ml-50ug/ml, and the particle diameter of nano silicon nitride silicon particle is 10-30nm.
Preferably, the condition of heating using microwave reaction is in the step (2):First react under 300W microwave powers 2.25min, then react 2.75min under 120W microwave powers.
The present invention has the advantages that:
1. the present invention replaces traditional hydro-thermal method to prepare nano-silicon nitride using microwave-hydrothermal method, with process is simple, life Cycle is short, energy-conserving and environment-protective are produced, the features such as having a safety feature.
2. the nano silicon nitride silicon grain using the method preparation is spherical in shape, uniform in size, good dispersion.
3. the support material requested of the present invention is simple, without the need for complicated technical requirements and high-end device requirement, low cost, It is easy to spread.
4. support of the present invention provides rational nano-silicon nitride slow-releasing system for the surface of a wound, provides permanently effective for the surface of a wound Medicament slow release, keeps the drug concentration of the surface of a wound balanced effective and not superfluous.
Specific embodiment
The present invention is further illustrated with reference to embodiment.
Embodiment 1
A kind of preparation method of the collagen-hydroxyapatite support containing nano-silicon nitride is realized by procedure below:
(1) adopting silicon tetrachloride and sodium azide and adding dipotassium hydrogen phosphate carries out Liquid reduction reaction process preparation for dispersant Nano silicon nitride Ludox;Plus the addition of dipotassium hydrogen phosphate is the 3% of tetra chlorauric acid quality;Reaction temperature is 40 DEG C;
(2) nano silicon nitride Ludox stirring 10min is taken, microwave heating treatment (selects the auspicious swan HX- in Beijing under airtight condition 300A computer microwaves ultrasound combinatorial compound instrument is microwave source), first 2.25min is reacted under 300W microwave powers, then it is micro- in 120W 2.75min is reacted under wave power, nano-silicon nitride solution is obtained;
(3) NTx albumen ox heel string originated and hydroxyapatite are according to 9:1 mass ratio is dissolved into 0.5mol/L Acetic acid solution in, added as aimed concn with 10ppm and mix 4h after a certain amount of solution to nano-silicon nitride, be subsequently adding total matter The glutaraldehyde of the 0.5% of amount is simultaneously mixed, and obtains the solution of collagen-hydroxyapatite containing nano-silicon nitride that mass fraction is 0.5%, Nano-silicon nitride, collagen-hydroxyapatite solution are injected into the mould of 4cm × 4cm, is freezed 2 hours at -20 DEG C, then frozen It is dry to obtain within 24 hours the collagen-hydroxyapatite support containing nano-silicon nitride that thickness is 2mm.The concentration range of nano-silicon nitride For 10ug/ml-50ug/ml, the particle diameter of nano silicon nitride silicon particle is 10-30nm.
Embodiment 2
A kind of preparation method of the collagen-hydroxyapatite support containing nano-silicon nitride is realized by procedure below:
(1) adopting silicon tetrachloride and sodium azide and adding dipotassium hydrogen phosphate carries out Liquid reduction reaction process preparation for dispersant Nano silicon nitride Ludox;Plus the addition of dipotassium hydrogen phosphate is the 3% of tetra chlorauric acid quality;Reaction temperature is 30 DEG C;
(2) nano silicon nitride Ludox stirring 10min is taken, microwave heating treatment (selects the auspicious swan HX- in Beijing under airtight condition 300A computer microwaves ultrasound combinatorial compound instrument is microwave source), first 2.5min is reacted under 250W microwave powers, then in 150W microwaves 2.5min is reacted under power, nano-silicon nitride solution is obtained;
(3) NTx albumen ox heel string originated and hydroxyapatite are according to 9:1 mass ratio is dissolved into 0.5mol/L Acetic acid solution in, added as aimed concn with 10ppm and mix 4h after a certain amount of solution to nano-silicon nitride, be subsequently adding total matter The glutaraldehyde of the 0.5% of amount is simultaneously mixed, obtain mass fraction be 0.5% it is molten containing nano-silicon nitride, collagen-hydroxyapatite Liquid, by nano-silicon nitride, collagen-hydroxyapatite solution the mould of 4cm × 4cm is injected, freezing 2 hours at -20 DEG C, then It is lyophilized to obtain within 24 hours collagen-hydroxyapatite support of the porous containing nano-silicon nitride that thickness is 2mm.Nano-silicon nitride it is dense Degree scope is 10ug/ml-50ug/ml, and the particle diameter of nano silicon nitride silicon particle is 10-30nm.
Although above-mentioned be described to the specific embodiment of the present invention in conjunction with the embodiments, not to present invention protection The restriction of scope, one of ordinary skill in the art should be understood that on the basis of technical scheme, those skilled in the art The various modifications made by creative work need not be paid or deformation are still within protection scope of the present invention.

Claims (2)

1. a kind of preparation method of the collagen-hydroxyapatite support containing nano-silicon nitride, is characterized in that, step is as follows:
(1) adopting silicon tetrachloride and sodium azide and adding dipotassium hydrogen phosphate carries out Liquid reduction reaction process preparation nanometer for dispersant Nitridation Ludox;Reaction temperature is 30 DEG C -45 DEG C;
(2) heating using microwave in confined conditions of nano silicon nitride Ludox is reacted, first reacts 2 under 250~350W microwave powers ~2.5min, then 2.5~3min is reacted under 100~150W microwave powers, nano-silicon nitride solution is obtained;
(3) by ox NTx albumen and shitosan according to 9:1 mass ratio is dissolved into the acetic acid solution of 0.5mol/L, with 10ppm is added to after nano-silicon nitride solution for aimed concn and mixes 4h, is subsequently adding the 0.5% of gross mass glutaraldehyde and mixes Even, it is 0.5% containing nano-silicon nitride, collagen-hydroxyapatite solution, by nano-silicon nitride, collagen-hydroxyl to obtain mass fraction Base apatite solution injects the mould of 4cm × 4cm, freezes at -20 DEG C 2 hours, then freezes and obtains within 24 hours thickness for 2mm Porous containing nano-silicon nitride collagen-hydroxyapatite support.
2. the preparation method of a kind of collagen-hydroxyapatite support containing nano-silicon nitride according to claim 1, it is special Levying is:The concentration range of nano-silicon nitride is 10ug/ml-50ug/ml, and the particle diameter of nano silicon nitride silicon particle is 10-30nm.
CN201610952850.0A 2016-11-03 2016-11-03 Preparation method of collagen-hydroxyapatite scaffold containing nano silicon nitride Pending CN106620862A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610952850.0A CN106620862A (en) 2016-11-03 2016-11-03 Preparation method of collagen-hydroxyapatite scaffold containing nano silicon nitride

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610952850.0A CN106620862A (en) 2016-11-03 2016-11-03 Preparation method of collagen-hydroxyapatite scaffold containing nano silicon nitride

Publications (1)

Publication Number Publication Date
CN106620862A true CN106620862A (en) 2017-05-10

Family

ID=58820408

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610952850.0A Pending CN106620862A (en) 2016-11-03 2016-11-03 Preparation method of collagen-hydroxyapatite scaffold containing nano silicon nitride

Country Status (1)

Country Link
CN (1) CN106620862A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022133908A1 (en) * 2020-12-24 2022-06-30 刘晓东 Ceramic composite coating material, antivirus ceramic composite coating material and preparation method therefor, and coating layer

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022133908A1 (en) * 2020-12-24 2022-06-30 刘晓东 Ceramic composite coating material, antivirus ceramic composite coating material and preparation method therefor, and coating layer

Similar Documents

Publication Publication Date Title
Zeng et al. Polydopamine nanoparticle-dotted food gum hydrogel with excellent antibacterial activity and rapid shape adaptability for accelerated bacteria-infected wound healing
Li et al. Construction of multifunctional hydrogel based on the tannic acid-metal coating decorated MoS2 dual nanozyme for bacteria-infected wound healing
CN106581766A (en) Preparation method of collagen-hydroxyapatite stent containing nanometer manganese dioxide
CN101693125A (en) Process for preparing biocompatible directional carbon nanotube array reinforced composite hydrogel
Qu et al. Bone cements for therapy and regeneration for minimally invasive treatment of neoplastic bone defects
Tang et al. Preparation and characterization of borate bioactive glass cross-linked PVA hydrogel
CN107501446A (en) A kind of preparation method of multifunctional nano composite aquogel
CN106512092A (en) Method for preparing collagen-hydroxy apatite scaffold containing nano copper phosphide
Li et al. A photothermal-response oxygen release platform based on a hydrogel for accelerating wound healing
CN106620862A (en) Preparation method of collagen-hydroxyapatite scaffold containing nano silicon nitride
CN106552290A (en) A kind of preparation method of the collagen hydroxyapatite support containing nano-copper sulfide
CN106563169A (en) Preparation method for preparing nano silicon dioxide-contained collagen-hydroxyapatite bracket
CN116747187A (en) Multifunctional iron-based photo-thermal controlled release agarose water gel system
CN106512094A (en) Preparation method of collagen-hydroxyapatite scaffold containing nano nickel phosphide
Ding et al. Sprayable Multifunctional Black Phosphorus Hydrogel with On‐Demand Removability for Joint Skin Wound Healing
CN106552292A (en) A kind of preparation method of the collagen hydroxyapatite support containing nano zine oxide
CN106540331A (en) A kind of preparation method of the collagen hydroxyapatite support containing silver sulfide nanometer particles
CN106581764A (en) Preparation method for collagen-hydroxylapatite scaffold containing nano boron nitride
CN106620867A (en) Preparation method of collagen-hydroxyapatite scaffold containing nano-iron nitride
CN106552291A (en) A kind of preparation method of the collagen hydroxyapatite support containing nano nickel sulphide
CN106563167A (en) Production method of nanometer magnesium nitride-containing collagen-hydroxyapatite stent
CN106620864A (en) Preparation method of collagen-hydroxyapatite scaffold containing nano aluminum nitride
CN106581767A (en) Preparation method of collagen-hydroxyapatite stent containing nanometer fluorapatite
CN106512093A (en) Preparation method of collagen-hydroxyapatite stent containing nano cadmium phosphide
CN106620868A (en) Preparation method of collagen-hydroxyapatite scaffold containing nano magnesia

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20170510

WD01 Invention patent application deemed withdrawn after publication